1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid Drugs Market Size 2024-2030
2.1.2 Nucleic Acid Drugs Market Size CAGR by Region
2.2 Nucleic Acid Drugs Segment by Type
2.2.1 Antisense Nucleic Acid Drugs
2.2.2 siRNA Drugs
2.2.3 saRNA Drugs
2.2.4 miRNA Drugs
2.2.5 mRNA Drugs
2.2.6 other
2.3 Nucleic Acid Drugs Market Size by Type
2.3.1 Global Nucleic Acid Drugs Market Size Market Share by Type (2024-2030)
2.3.2 Global Nucleic Acid Drugs Market Size Growth Rate by Type (2024-2030)
2.4 Nucleic Acid Drugs Segment by Application
2.4.1 Genetic Disease
2.4.2 Cancer
2.4.3 Cardiovascular Diseases
2.4.4 Other
2.5 Nucleic Acid Drugs Market Size by Application
2.5.1 Global Nucleic Acid Drugs Market Size Market Share by Application (2024-2030)
2.5.2 Global Nucleic Acid Drugs Market Size Growth Rate by Application (2024-2030)
3 Nucleic Acid Drugs Key Players
3.1 Date of Key Players Enter into Nucleic Acid Drugs
3.2 Key Players Nucleic Acid Drugs Product Offered
3.3 Key Players Nucleic Acid Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Nucleic Acid Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Nucleic Acid Drugs by Regions
4.1 Nucleic Acid Drugs Market Size by Regions (2024-2030)
4.2 United States Nucleic Acid Drugs Market Size Growth (2024-2030)
4.3 China Nucleic Acid Drugs Market Size Growth (2024-2030)
4.4 Europe Nucleic Acid Drugs Market Size Growth (2024-2030)
4.5 Rest of World Nucleic Acid Drugs Market Size Growth (2024-2030)
5 United States
5.1 United States Nucleic Acid Drugs Market Size by Type (2024-2030)
5.2 United States Nucleic Acid Drugs Market Size by Application (2024-2030)
6 Europe
6.1 Europe Nucleic Acid Drugs Market Size by Type (2024-2030)
6.2 Europe Nucleic Acid Drugs Market Size by Application (2024-2030)
7 China
7.1 China Nucleic Acid Drugs Market Size by Type (2024-2030)
7.2 China Nucleic Acid Drugs Market Size by Application (2024-2030)
8 Rest of World
8.1 Rest of World Nucleic Acid Drugs Market Size by Type (2024-2030)
8.2 Rest of World Nucleic Acid Drugs Market Size by Application (2024-2030)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Nucleic Acid Drugs
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Sarepta Therapeutics
11.1.1 Sarepta Therapeutics Company Details
11.1.2 Sarepta Therapeutics Nucleic Acid Drugs Product Offered
11.1.3 Sarepta Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
11.1.4 Sarepta Therapeutics Main Business Overview
11.1.5 Sarepta Therapeutics News
11.2 Ionis Pharmaceuticals
11.2.1 Ionis Pharmaceuticals Company Details
11.2.2 Ionis Pharmaceuticals Nucleic Acid Drugs Product Offered
11.2.3 Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2024 VS 2030)
11.2.4 Ionis Pharmaceuticals Main Business Overview
11.2.5 Ionis Pharmaceuticals News
11.3 Alnylam
11.3.1 Alnylam Company Details
11.3.2 Alnylam Nucleic Acid Drugs Product Offered
11.3.3 Alnylam Nucleic Acid Drugs Market Size (2024 VS 2030)
11.3.4 Alnylam Main Business Overview
11.3.5 Alnylam News
11.4 Mina Therapeutics
11.4.1 Mina Therapeutics Company Details
11.4.2 Mina Therapeutics Nucleic Acid Drugs Product Offered
11.4.3 Mina Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
11.4.4 Mina Therapeutics Main Business Overview
11.4.5 Mina Therapeutics News
11.5 BioNTech
11.5.1 BioNTech Company Details
11.5.2 BioNTech Nucleic Acid Drugs Product Offered
11.5.3 BioNTech Nucleic Acid Drugs Market Size (2024 VS 2030)
11.5.4 BioNTech Main Business Overview
11.5.5 BioNTech News
11.6 NeXstar Pharmaceuticals
11.6.1 NeXstar Pharmaceuticals Company Details
11.6.2 NeXstar Pharmaceuticals Nucleic Acid Drugs Product Offered
11.6.3 NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2024 VS 2030)
11.6.4 NeXstar Pharmaceuticals Main Business Overview
11.6.5 NeXstar Pharmaceuticals News
11.7 Nippon Shinyaku
11.7.1 Nippon Shinyaku Company Details
11.7.2 Nippon Shinyaku Nucleic Acid Drugs Product Offered
11.7.3 Nippon Shinyaku Nucleic Acid Drugs Market Size (2024 VS 2030)
11.7.4 Nippon Shinyaku Main Business Overview
11.7.5 Nippon Shinyaku News
11.8 Moderna Therapeutics
11.8.1 Moderna Therapeutics Company Details
11.8.2 Moderna Therapeutics Nucleic Acid Drugs Product Offered
11.8.3 Moderna Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
11.8.4 Moderna Therapeutics Main Business Overview
11.8.5 Moderna Therapeutics News
11.9 CureVac
11.9.1 CureVac Company Details
11.9.2 CureVac Nucleic Acid Drugs Product Offered
11.9.3 CureVac Nucleic Acid Drugs Market Size (2024 VS 2030)
11.9.4 CureVac Main Business Overview
11.9.5 CureVac News
11.10 Regulus Therapeutics
11.10.1 Regulus Therapeutics Company Details
11.10.2 Regulus Therapeutics Nucleic Acid Drugs Product Offered
11.10.3 Regulus Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
11.10.4 Regulus Therapeutics Main Business Overview
11.10.5 Regulus Therapeutics News
11.11 Miragen Therapeutics
12 Research Findings and Conclusion
List of Tables
Table 1. Nucleic Acid Drugs Market Size CAGR by Region (2024-2030) ($ Millions)
Table 2. Major Players of Antisense Nucleic Acid Drugs
Table 3. Major Players of siRNA Drugs
Table 4. Major Players of saRNA Drugs
Table 5. Major Players of miRNA Drugs
Table 6. Major Players of mRNA Drugs
Table 7. Major Players of other
Table 8. Global Nucleic Acid Drugs Market Size by Type (2024-2030) ($ Millions)
Table 9. Global Nucleic Acid Drugs Market Size Market Share by Type (2024-2030)
Table 10. Global Nucleic Acid Drugs Market Size by Application (2024-2030) ($ Millions)
Table 11. Global Nucleic Acid Drugs Market Size Market Share by Application (2024-2030)
Table 12. Date of Global Key Players Enter into Nucleic Acid Drugs Market
Table 13. Global Key Players Nucleic Acid Drugs Product Offered
Table 14. Key Players Nucleic Acid Drugs Funding/Investment ($ Millions)
Table 15. Funding/Investment by Regions
Table 16. Funding/Investment by End Industry
Table 17. Key Players Nucleic Acid Drugs Valuation & Market Capitalization ($ Millions)
Table 18. Key Players Mergers & Acquisitions, Expansion Plans
Table 19. Nucleic Acid Drugs New Product/Technology Launches
Table 20. Nucleic Acid Drugs Industry Partnerships, Agreements, and Collaborations
Table 21. Nucleic Acid Drugs Industry Mergers and Acquisitions
Table 22. Global Nucleic Acid Drugs Market Size by Regions 2024-2030 ($ Millions)
Table 23. Global Nucleic Acid Drugs Market Size Market Share by Regions 2024-2030
Table 24. United States Nucleic Acid Drugs Market Size by Type (2024-2030) ($ Millions)
Table 25. United States Nucleic Acid Drugs Market Size Market Share by Type (2024-2030)
Table 26. United States Nucleic Acid Drugs Market Size by Application (2024-2030) ($ Millions)
Table 27. United States Nucleic Acid Drugs Market Size Market Share by Application (2024-2030)
Table 28. Europe Nucleic Acid Drugs Market Size by Type (2024-2030) ($ Millions)
Table 29. Europe Nucleic Acid Drugs Market Size Market Share by Type (2024-2030)
Table 30. Europe Nucleic Acid Drugs Market Size by Application (2024-2030) ($ Millions)
Table 31. Europe Nucleic Acid Drugs Market Size Market Share by Application (2024-2030)
Table 32. China Nucleic Acid Drugs Market Size by Type (2024-2030) ($ Millions)
Table 33. China Nucleic Acid Drugs Market Size Market Share by Type (2024-2030)
Table 34. China Nucleic Acid Drugs Market Size by Application (2024-2030) ($ Millions)
Table 35. China Nucleic Acid Drugs Market Size Market Share by Application (2024-2030)
Table 36. Rest of World Nucleic Acid Drugs Market Size by Type (2024-2030) ($ Millions)
Table 37. Rest of World Nucleic Acid Drugs Market Size Market Share by Type (2024-2030)
Table 38. Rest of World Nucleic Acid Drugs Market Size by Application (2024-2030) ($ Millions)
Table 39. Rest of World Nucleic Acid Drugs Market Size Market Share by Application (2024-2030)
Table 40. Key Market Drivers & Growth Opportunities of Nucleic Acid Drugs
Table 41. Key Market Challenges & Risks of Nucleic Acid Drugs
Table 42. Key Industry Trends of Nucleic Acid Drugs
Table 43. Company A Company Details
Table 44. Companies Invested by Company A
Table 45. Company A Key Development and Market Layout
Table 46. Company B Company Details
Table 47. Companies Invested by Company B
Table 48. Company B Key Development and Market Layout
Table 49. Company C Company Details
Table 50. Companies Invested by Company C
Table 51. Company C Key Development and Market Layout
Table 52. Company C Company Details
Table 53. Companies Invested by Company C
Table 54. Company C Key Development and Market Layout
Table 55. Sarepta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. Sarepta Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 57. Ionis Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Ionis Pharmaceuticals Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 59. Alnylam Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Alnylam Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 61. Mina Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Mina Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 63. BioNTech Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. BioNTech Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 65. NeXstar Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. NeXstar Pharmaceuticals Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 67. Nippon Shinyaku Basic Information, Head Office, Major Market Areas and Its Competitors
Table 68. Nippon Shinyaku Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 69. Moderna Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 70. Moderna Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 71. CureVac Basic Information, Head Office, Major Market Areas and Its Competitors
Table 72. CureVac Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 73. Regulus Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 74. Regulus Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
Table 75. Miragen Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 76. Miragen Therapeutics Nucleic Acid Drugs Market Size (2024 VS 2030)
List of Figures
Figure 1. Picture of Nucleic Acid Drugs
Figure 2. Nucleic Acid Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nucleic Acid Drugs Market Size Growth Rate 2024-2030 ($ Millions)
Figure 7. Nucleic Acid Drugs Market Size by Region (2024 & 2030) ($ millions)
Figure 8. Global Nucleic Acid Drugs Market Size Market Share by Type (2024-2030)
Figure 9. Global Antisense Nucleic Acid Drugs Market Size Growth Rate
Figure 10. Global siRNA Drugs Market Size Growth Rate
Figure 11. Global saRNA Drugs Market Size Growth Rate
Figure 12. Global miRNA Drugs Market Size Growth Rate
Figure 13. Global mRNA Drugs Market Size Growth Rate
Figure 14. Global other Market Size Growth Rate
Figure 15. Nucleic Acid Drugs in Genetic Disease
Figure 16. Global Nucleic Acid Drugs Market: Genetic Disease (2024-2030) ($ Millions)
Figure 17. Nucleic Acid Drugs in Cancer
Figure 18. Global Nucleic Acid Drugs Market: Cancer (2024-2030) ($ Millions)
Figure 19. Nucleic Acid Drugs in Cardiovascular Diseases
Figure 20. Global Nucleic Acid Drugs Market: Cardiovascular Diseases (2024-2030) ($ Millions)
Figure 21. Nucleic Acid Drugs in Other
Figure 22. Global Nucleic Acid Drugs Market: Other (2024-2030) ($ Millions)
Figure 23. Global Nucleic Acid Drugs Market Size Market Share by Application (2024-2030)
Figure 24. Global Nucleic Acid Drugs Market Size in Genetic Disease Growth Rate
Figure 25. Global Nucleic Acid Drugs Market Size in Cancer Growth Rate
Figure 26. Global Nucleic Acid Drugs Market Size in Cardiovascular Diseases Growth Rate
Figure 27. Global Nucleic Acid Drugs Market Size in Other Growth Rate
Figure 28. Funding/Investment
Figure 29. Global Nucleic Acid Drugs Market Size Market Share by Regions 2024-2030
Figure 30. United States Nucleic Acid Drugs Market Size 2024-2030 ($ Millions)
Figure 31. China Nucleic Acid Drugs Market Size 2024-2030 ($ Millions)
Figure 32. Europe Nucleic Acid Drugs Market Size 2024-2030 ($ Millions)
Figure 33. Rest of World Nucleic Acid Drugs Market Size 2024-2030 ($ Millions)
Figure 34. United States Nucleic Acid Drugs Consumption Market Share by Type in 2030
Figure 35. United States Nucleic Acid Drugs Market Size Market Share by Application in 2030
Figure 36. China Nucleic Acid Drugs Consumption Market Share by Type in 2030
Figure 37. China Nucleic Acid Drugs Market Size Market Share by Application in 2030
Figure 38. Europe Nucleic Acid Drugs Consumption Market Share by Type in 2030
Figure 39. Europe Nucleic Acid Drugs Market Size Market Share by Application in 2030
Figure 40. Rest of World Nucleic Acid Drugs Consumption Market Share by Type in 2030
Figure 41. Rest of World Nucleic Acid Drugs Market Size Market Share by Application in 2030
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sarepta Therapeutics|||Ionis Pharmaceuticals|||Alnylam|||Mina Therapeutics|||BioNTech|||NeXstar Pharmaceuticals|||Nippon Shinyaku|||Moderna Therapeutics|||CureVac|||Regulus Therapeutics|||Miragen Therapeutics